1. MARKETS
  2. SECTOR : OTHERS
  3. INDUSTRY : OTHERS
  4. RAPPORT THERAPEUTICS INC.
Rapport Therapeutics Inc. XNAS: RAPP

Rapport Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

about

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucid...

Read More
15.42 -1.32 (-7.89%)
48.15% Fall from 52W High
213.2K
XNAS Volume

XNAS 29 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Rapport Therapeutics Inc. is on 08 Aug 2025 for the purpose of Rapport Therapeutics Inc Second Quarter Earnings Results for 2025 See details
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
11.3 / 100
Momentum Score
Technically Moderately Bullish
60.5 / 100
Analyst Price Target
No estimates available

16

S

6

W

4

O

2

T

SWOT Analysis

Rapport Therapeutics Inc. Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..